UPMC Physician Resources

NCI Renews UPCI’s Comprehensive Cancer Center Status

The National Cancer Institute (NCI) has renewed the University of Pittsburgh Cancer Institute’s (UPCI) status as a “Comprehensive Cancer Center,” the highest distinction granted to cancer centers by the NCI. With this designation comes national and international recognition as a center of excellence in basic and clinical research, prevention and control and population sciences, as well as a vital part of the regional community for cancer education and outreach.

Watch Nancy E. Davidson, MD, director of UPCI and UPMC Cancer Centers discuss how the distinction benefits the western Pennsylvania region and beyond:


UPMC Cancer Centers launches Mesothelioma Specialty Care Center

Located at Hillman Cancer Center, the Mesothelioma Specialty Care Center of UPMC Cancer Centers and the University of Pittsburgh Cancer Institute  offers specialized care for patients with mesothelioma through a multimodality treatment program that incorporates surgery, chemotherapy, and radiation therapies for patients with localized disease.

 

Watch David L. Bartlett, MD, vice chair,  Surgical Oncology Services, discuss the benefits of the new Center:


Vaccine trial targets recurrent malignant gliomas

In a study conducted at the University of Pittsburgh Cancer Institute (UPCI), a novel dendritic-cell based vaccine in combination with poly-ICLC demonstrated safety, immune-reactivity, as well as efficacy in patients with recurrent malignant gliomas.

UPCI researchers presented their findings at the ASCO annual meeting in Chicago.

Watch Hideho Okada, MD, PhD, co-leader, Brain Tumor Program, UPCI, and associate professor of neurological surgery, Surgery and Immunology, University of Pittsburgh School of Medicine,  and Pawel Kalinski, MD, PhD, director of research, Division of Surgical Oncology, UPCI, and professor of surgery, University of Pittsburgh School of Medicine, discuss the oral presentation:

Analysis of Ribbon-2 study demonstrates significant response rates in patients with triple negative breast cancer when treated with bevacizumab and second-line chemotherapy

Analysis of patients with triple negative breast cancer demonstrated significant response rates and longer progression free survival from the combination of bevacizumab with second-line chemotherapy.

Cooperative group researchers presented their findings at the ASCO annual meeting in Chicago.

Watch Adam Brufsky, MD, PhD, co-director,  Breast Cancer Program and associate director of clinical investigation, UPCI, and professor of medicine, University of Pittsburgh School of Medicine, discuss the oral presentation:

Study evaluating cetuximab with concomitant radiotherapy followed by consolidation therapy in patients with locally advanced nonsmall cell lung cancer finds novel treatment strategy toxicities and efficacy comparable to RT/CT

A University of Pittsburgh Cancer Institute (UPCI) study evaluated a novel treatment strategy of cetuximab with concomitant radiotherapy followed by consolidation chemotherapy in locally advanced nonsmall cell lung cancer.

UPCI researchers presented their findings at the ASCO annual meeting in Chicago.

Watch Dwight E. Heron, MD, FACRO, director of Radiation Services, UPMC Cancer Centers, and professor of radiation oncology, University of Pittsburgh School of Medicine, discuss the poster presentation:

Study shows extended duration of response with second-line intraperitoneal platinum-based therapy for epithelial ovarian cancer

A Magee-Womens Gynecologic Oncology Program of UPMC Cancer Centers study demonstrated an extended duration of response with second-line intraperitoneal platinum-based therapy for patients with epithelial ovarian cancer.

Magee researchers presented their findings aT the ASCO annual meeting in Chicago.

Watch Robert Edwards, MD, senior investigator, Magee-Womens Research Institute, and professor, Division of Gynecologic Oncology, UPMC, discuss the poster presentation:

Study finds perspectives on Electronic Health Information Exchange among people affected by cancer to be positive

According to a recent study, people affected by cancer are willing to facilitate information exchange between their providers, actively self-enter personal data, and have their de-identified data contribute support research through electronic health information exchange.

University of Pittsburgh Cancer Institute (UPCI) and UPMC Cancer Centers researchers presented their findings at the ASCO annual meeting in Chicago.

Watch Ellen Beckjord, PhD, assistant professor, Department of Psychiatry, University of Pittsburgh Biobehavioral Medicine in Oncology Program, discuss the poster presentation:

Analysis of breast cancer patients treated with docetaxel plus cyclophospamide shows incidence of febrile neutropenia to be higher than expected

 An analysis conducted by the Magee-Womens Breast Cancer Program  of UPMC Cancer Centers found that the incidence of febrile neutropenia was higher than expected in breast cancer patients treated with docetaxel plus cyclophosphamide.

Magee-Womens Breast Cancer Program researchers presented their findings at the Annual ASCO meeting in Chicago.

WatchShannon Puhalla, MD, breast oncologist, Magee-Womens Breast Cancer Program  and assistant professor of medicine, University of Pittsburgh School of medicine, and Amy Soni, MD, resident, internal medicine, Magee-Womens Hospital of UPMC, discuss the ASCO poster presentation:

Levrat model study evaluates role of smoothened inhibitors in the progression of Barrett’s Esophagus and esophageal adenocarcinoma

A University of Pittsburgh Cancer Institute (UPCI) study used the Levrat model to evaluate the role of smoothened inhibitor, BMS 833293, in the progression of Barrett’s Esophagus and esophageal adenocarcinoma.

UPCI researchers presented their findings at the ASCO annual meeting in Chicago.

Watch Michael Gibson, MD, co-leader, Esophageal Program, UPCI, and assistant professor of medicine, University of Pittsburgh School of Medicine, discuss the poster presentation:

Breast cancer study confirms risk associated with smoking and fitness, but not reported associations with excessive alcohol use

A prospective study in women at high risk for breast cancer confirms previously reported cancer risk associated with smoking and fitness, but did not confirm previously reported associations with excessive alcohol use.

National Surgical Adjuvant Breast and Bowel Project (NSABP) researchers presented their findings at the annual ASCO meeting in Chicago.

Watch Stephanie Land, PhD, research associate professor, Department of Biostatistics, University of Pittsburgh, discuss the oral presentation:

Page 20 of 20:« First« 17 18 19 20
  • Make A Referral

    To refer a patient, call UPMC’s 24-hour physician referral service at 1-800-544-2500 or e-mail us.
  • Information for your Patients

    UPMC’s Clinical Services page provides information for your patients on services, conditions, and treatments.